Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.

CEO

Dror Harats

Employees

Country

Israel

ISIN

IL0012002452

Listings

OTC Link

NTBLQ

0 Comments

Share your thoughts

FAQ

What is Notable Labs stock price today?▼

The current price of NTBL is $0.25 USD — it has decreased by -27.68% in the past 24 hours. Watch Notable Labs stock price performance more closely on the chart.

What is Notable Labs stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Notable Labs stocks are traded under the ticker NTBL.

What is Notable Labs revenue for the last year?▼

Notable Labs revenue for the last year amounts to 620,000 USD.

What is Notable Labs net income for the last year?▼

NTBL net income for the last year is -22.53M USD.

How many employees does Notable Labs have?▼

As of September 04, 2026, the company has 16 employees.

In which sector is Notable Labs located?▼

Notable Labs operates in the Technology sector.

When did Notable Labs complete a stock split?▼

The last stock split for Notable Labs was on October 17, 2023 with a ratio of 1:35.

Where is Notable Labs headquartered?▼

Notable Labs is headquartered in 8 Hasatat St, Israel.